These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22653658

  • 1. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
    Sellebjerg F, Hesse D, Limborg S, Lund H, Søndergaard HB, Krakauer M, Sørensen PS.
    Mult Scler; 2013 Feb; 19(2):179-87. PubMed ID: 22653658
    [Abstract] [Full Text] [Related]

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG.
    Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
    [Abstract] [Full Text] [Related]

  • 6. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
    Mitosek-Szewczyk K, Tabarkiewicz J, Wilczynska B, Lobejko K, Berbecki J, Nastaj M, Dworzanska E, Kolodziejczyk B, Stelmasiak Z, Rolinski J.
    J Neurol Sci; 2013 Sep 15; 332(1-2):35-40. PubMed ID: 23835090
    [Abstract] [Full Text] [Related]

  • 7. Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis.
    Sanna A, Fois ML, Arru G, Huang YM, Link H, Pugliatti M, Rosati G, Sotgiu S.
    Clin Exp Immunol; 2006 Feb 15; 143(2):357-62. PubMed ID: 16412061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
    Karandikar NJ, Crawford MP, Yan X, Ratts RB, Brenchley JM, Ambrozak DR, Lovett-Racke AE, Frohman EM, Stastny P, Douek DC, Koup RA, Racke MK.
    J Clin Invest; 2002 Mar 15; 109(5):641-9. PubMed ID: 11877472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
    Carrieri PB, Carbone F, Perna F, Bruzzese D, La Rocca C, Galgani M, Montella S, Petracca M, Florio C, Maniscalco GT, Spitaleri DL, Iuliano G, Tedeschi G, Della Corte M, Bonavita S, Matarese G.
    Metabolism; 2015 Sep 15; 64(9):1112-21. PubMed ID: 25986733
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH.
    Ann Neurol; 2010 Apr 15; 67(4):452-61. PubMed ID: 20437580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo.
    Weber MS, Starck M, Wagenpfeil S, Meinl E, Hohlfeld R, Farina C.
    Brain; 2004 Jun 15; 127(Pt 6):1370-8. PubMed ID: 15090474
    [Abstract] [Full Text] [Related]

  • 20. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Schrempf W, Ziemssen T.
    Autoimmun Rev; 2007 Aug 15; 6(7):469-75. PubMed ID: 17643935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.